Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer

Gynecologic Oncology

Volumn 125, Issue 1, 2012, Pages 25-30

  Barlin, Joyce N ^a   Yu, Changhong ^b   Hill, Emily K ^c   Zivanovic, Oliver ^a,e   Kolev, Valentin ^d   Levine, Douglas A ^a   Sonoda, Yukio ^a   Abu Rustum, Nadeem R ^a   Huh, Jae ^a   Barakat, Richard R ^a   Kattan, Michael W ^b   Chi, Dennis S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c BROWN UNIVERSITY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

Cytoreductive surgery; Nomogram; Ovarian carcinoma; Survival

Indexed keywords

ALBUMIN;

ACCURACY; ADULT; AGED; ALBUMIN BLOOD LEVEL; ANESTHESIST; ARTICLE; BOOTSTRAPPING; BREAST CANCER; CALIBRATION; CANCER CENTER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; EPITHELIAL OVARIAN CANCER; FEMALE; FEMALE GENITAL SYSTEM; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; NOMOGRAM; OVARY CANCER; PATHOLOGY; PATIENT COUNSELING; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRIDGED COMPOUNDS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; NOMOGRAMS; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; TAXOIDS; TREATMENT OUTCOME;

EID: 84858332616     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.12.423     Document Type: Article

References (24)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. Staging announcement: FIGO Cancer Committee Gynecol Oncol 25 1986 383 385
3. G.A. Omura, M.F. Brady, H.D. Homesley, E. Yordan, F.J. Major, and H.J. Buchsbaum Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience J Clin Oncol 9 1991 1138 1150
4. T. Thigpen, M.F. Brady, G.A. Omura, W.T. Creasman, W.P. McGuire, and W.J. Hoskins Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience Cancer 71 1993 606 614
5. D.S. Chi, J.B. Liao, L.F. Leon, E.S. Venkatraman, M.L. Hensley, and D. Bhaskaran Identification of prognostic factors in advanced epithelial ovarian carcinoma Gynecol Oncol 82 2001 532 537 (Pubitemid 32826455)
6. T.G. Clark, M.E. Stewart, D.G. Altman, D.G. Altman, H. Gabra, and J.F. Smyth A prognostic model for ovarian cancer Br J Cancer 85 2001 944 952 (Pubitemid 33015994)
7. L. Zhang, J.R. Conejo-Garcia, D. Katsaros, P.A. Gimotty, M. Massobrio, and G. Regnani Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N Engl J Med 348 2003 203 213 (Pubitemid 36077915)
8. J.C. van Houwelingen, W.W. ten Bokkel Huinink, M.E. van der Burg, A.T. van Oosterom, and J.P. Neijt Predictability of the survival of patients with advanced ovarian cancer J Clin Oncol 7 1989 769 773 (Pubitemid 19145599)
9. S. Marsoni, V. Torri, M.G. Valsecchi, C. Belloni, U. Bianchi, and G. Bolis Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG) Br J Cancer 62 1990 444 450
10. B. Lund, P. Williamson, H.C. van Houwelingen, and J.P. Neijt Comparison of the predictive power of different prognostic indices for overall survival in patients with advanced ovarian carcinoma Cancer Res 50 1990 4626 4629 (Pubitemid 20230403)
11. D.J. Gallagher, J.A. Konner, K.M. Bell-McGuinn, J. Bhatia, P. Sabbatini, and C.A. Aghajanian Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity Ann Oncol 22 2010 1127 1132
12. M.W. Kattan, M.J. Zelefsky, P.A. Kupelian, D. Cho, P.T. Scardino, and Z. Fuks Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer J Clin Oncol 18 2000 3352 3359
13. M.W. Kattan, D.H. Leung, and M.F. Brennan Postoperative nomogram for 12-year sarcoma-specific death J Clin Oncol 20 2002 791 796 (Pubitemid 34111387)
14. M.W. Kattan, M.S. Karpeh, M. Mazumdar, and M.F. Brennan Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma J Clin Oncol 21 2003 3647 3650 (Pubitemid 46594058)
15. D.S. Chi, M.J. Palayekar, Y. Sonoda, N.R. Abu-Rustum, C.S. Awtrey, and J. Huh Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma Gynecol Oncol 108 2008 191 194 (Pubitemid 350299443)
16. C.G. Gerestein, M.J. Eijkemans, D. de Jong, M.E. van der Burg, R.H. Dykgraaf, and G.S. Kooi The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma BJOG 116 2009 372 380
17. S.F.S.R. Serov, and L.H. Sobin Histologic typing of ovarian tumors International histologic classification of tumors 17 1973 World Health Organization Geneva
18. R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
19. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
20. M. Wolbers, M.T. Koller, J.C. Witteman, and E.W. Steyerberg Prognostic models with competing risks: methods and application to coronary risk prediction Epidemiology 20 2009 555 561
21. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387 (Pubitemid 26072233)
22. A.J. Vickers, and E.B. Elkin Decision curve analysis: a novel method for evaluating prediction models Med Decis Making 26 2006 565 574 (Pubitemid 44728772)
23. S. Teramukai, K. Ochiai, H. Tada, M. Fukushima, and Japan Multinational Trial Organization OC01-01 PIEPOC: a new prognostic index for advanced epithelial ovarian cancer-Japan Multinational Trial Organization OC01-01 J Clin Oncol 25 2007 3302 3306 (Pubitemid 47325616)
24. T.G. Clark, M. Stewart, T. Rye, J.F. Smyth, and C. Gourley Validation of a new prognostic index for advanced epithelial ovarian cancer: results from its application to a UK-based cohort J Clin Oncol 25 2007 5669 5670 [author reply 70-71]